Oggi Sabato, 30 Agosto 2025
04:00 - 04:30
Medical Frontiers
While immune checkpoint inhibitors can improve cancer survival rates, they only work in about 20 to 30 per cent of patients - we interview Japanese researchers trying to overcome this challenge.